Lasola, Emie .

HRN: 11-97-04  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/22/2023
AMPICILLIN 1GM (VIAL)
11/22/2023
11/23/2023
IV
2 G
IVTT
PROM X 6 Hrs, MSAF Thinly
Checking Final Appropriateness 
11/22/2023
MUPIROCIN 2%, 15G (TUBE)
11/22/2023
11/29/2023
TOPICAL
Apply On Affected Area
BID
Abrasion On Keft Knee
Checking Final Appropriateness 
11/22/2023
CEFUROXIME 500MG (TAB)
11/22/2023
11/29/2023
PO
500 Mg
BID
S/P NSVD
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: